Cargando…

Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166174/
https://www.ncbi.nlm.nih.gov/pubmed/36892975
http://dx.doi.org/10.1093/oncolo/oyad071
_version_ 1785038390643654656
collection PubMed
description
format Online
Article
Text
id pubmed-10166174
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101661742023-05-09 Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs Oncologist Correction Notice Oxford University Press 2023-03-09 /pmc/articles/PMC10166174/ /pubmed/36892975 http://dx.doi.org/10.1093/oncolo/oyad071 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Correction Notice
Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
title Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
title_full Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
title_fullStr Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
title_full_unstemmed Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
title_short Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
title_sort correction to: physician payments from pharmaceutical companies related to cancer drugs
topic Correction Notice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166174/
https://www.ncbi.nlm.nih.gov/pubmed/36892975
http://dx.doi.org/10.1093/oncolo/oyad071